Replies to post #14755 on Aurinia Pharmaceuticals Inc (AUPH)

[greggors]

So auph has a negative growth rate of 53%, sounds good to me…:-)

Five analysts have issued estimates for Aurinia Pharmaceuticals’ earnings. The highest sales estimate is $26.70 million and the lowest is $20.29 million. Aurinia Pharmaceuticals posted sales of $50.03 million in the same quarter last year, which would indicate a negative year-over-year growth rate of 53.6%. The firm is scheduled to announce its next earnings results on Wednesday, February 23rd.